Hypoglycaemia risk is highest in patients also taking sulphonylureas or insulin, those fasting, or those with renal impairment
That means pharmacies and outsourcing facilities can no longer legally compound these drugs under the exemptions provided by federal law
Summary of completed and ongoing clinical trials of GLP-1RAs for neurodegeneration In summary, clinical trials investigating GLP-1RAs in neurodegenerative diseases have yielded contrasting outcomes
Sullivan, N., Sun, Y., Li, J., Hofmann, W
The decision comes down to where you are in your dosing protocol
This guide explores the potential risks of excessive intake, how to recognise when your body has had enough, and why a balanced approach is essential for long-term wellness